Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;334:652 (31 March), doi:10.1136/bmj.39164.410532.1F
Although it may be preferable to predict outcomes and allow for death in the community, numerous patients with chronic illnesses in whom death may be expected or patients with severe and significant comorbidites will be admitted to acute medicine.1
We recently performed a retrospective audit of patients admitted through the medical admissions unit who subsequently died. Death did not come as a surprise in 21/23 patients; seven of the 21 patients had terminal cancer, and nine had severe infection with severe comorbidities. An average delay of 11 hours occurred from recognition that the patient was dying to institution of any palliative measures. Of the terminally ill patients, six were judged to have had adequate palliation, 10 received no palliative drugs, and five received minimal palliation. The commonest reason for withholding palliative drugs seemed to be a trial of active treatment in the first instance.
Care of dying patients in acute medicine may not always be seen as a priority. However, these patients should be recognised earlyso that symptomatic treatment can be used to ensure a comfortable death and enable the patient and family to prepare for death.2 These measures can be instituted alongside active management (where appropriate) in this group of patients who are sick enough to die.
Suzie Gillon, senior house officer, general medicine, Kathryn Mannix, consultant in palliative care, David A Price, consultant in acute medicine (and infectious diseases)
Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP
suziegillon{at}doctors.org.uk
Read all Rapid Responses